Specifically, Wnt signaling activation in metaplastic breast cancers is caused mainly by genetic changes, such as CTNNB1 and APC mutations [287], whereas Wnt signaling activation in BLBCs and TNBCs is associated mainly with the strong expression of nuclear β-Catenin [256, 257]. Here, APC is linked to breast cancer.